These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17705673)

  • 1. Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and -1131C.
    Kovář J; Adámková V
    Physiol Res; 2008; 57(4):555-561. PubMed ID: 17705673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant.
    Mero N; Suurinkeroinen L; Syvänne M; Knudsen P; Yki-Järvinen H; Taskinen MR
    J Lipid Res; 1999 Sep; 40(9):1663-70. PubMed ID: 10484613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects.
    Masana L; Ribalta J; Salazar J; Fernández-Ballart J; Joven J; Cabezas MC
    Clin Chem Lab Med; 2003 Apr; 41(4):517-21. PubMed ID: 12747596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
    Dorfmeister B; Zeng WW; Dichlberger A; Nilsson SK; Schaap FG; Hubacek JA; Merkel M; Cooper JA; Lookene A; Putt W; Whittall R; Lee PJ; Lins L; Delsaux N; Nierman M; Kuivenhoven JA; Kastelein JJ; Vrablik M; Olivecrona G; Schneider WJ; Heeren J; Humphries SE; Talmud PJ
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1866-71. PubMed ID: 18635818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
    Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
    J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers.
    Nierman MC; Prinsen BH; Rip J; Veldman RJ; Kuivenhoven JA; Kastelein JJ; de Sain-van der Velden MG; Stroes ES
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2410-5. PubMed ID: 16195478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose added to a fat load suppresses the postprandial triglyceridemia response in carriers of the -1131C and 56G variants of the APOA5 gene.
    Zemánková K; Dembovská R; Piťha J; Kovář J
    Physiol Res; 2017 Nov; 66(5):859-866. PubMed ID: 28730827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
    Vaessen SF; Sierts JA; Kuivenhoven JA; Schaap FG
    Biochem Biophys Res Commun; 2009 Feb; 379(2):542-6. PubMed ID: 19121291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
    Vaessen SF; Dallinga-Thie GM; Ross CJ; Splint LJ; Castellani LW; Rensen PC; Hayden MR; Schaap FG; Kuivenhoven JA
    J Lipid Res; 2009 May; 50(5):880-4. PubMed ID: 19141870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of plasma very-low-density lipoprotein concentration and composition in premenopausal women.
    Després JP; Moorjani S; Pouliot MC; Tremblay A; Nadeau A; Lupien PJ; Bouchard C
    Metabolism; 1990 Jun; 39(6):577-83. PubMed ID: 2191186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
    Shu X; Nelbach L; Weinstein MM; Burgess BL; Beckstead JA; Young SG; Ryan RO; Forte TM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2504-9. PubMed ID: 20966404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
    Novotny D; Vaverkova H; Karasek D; Malina P
    Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study.
    Garenc C; Pérusse L; Gagnon J; Chagnon YC; Bergeron J; Després JP; Province MA; Leon AS; Skinner JS; Wilmore JH; Rao DC; Bouchard C
    Metabolism; 2000 Apr; 49(4):432-9. PubMed ID: 10778864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).
    Kim JY; Kim OY; Koh SJ; Jang Y; Yun SS; Ordovas JM; Lee JH
    J Am Coll Nutr; 2006 Aug; 25(4):340-7. PubMed ID: 16943456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study.
    Lai CQ; Corella D; Demissie S; Cupples LA; Adiconis X; Zhu Y; Parnell LD; Tucker KL; Ordovas JM
    Circulation; 2006 May; 113(17):2062-70. PubMed ID: 16636175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.